Osteoporosis

In an update to its guidance on primary osteoporosis, ACP recommended bisphosphonates as a first line of defense to reduce fracture risk in men and postmenopausal women.

The FDA has approved abaloparatide, a parathyroid hormone-related peptide analog, to increase bone mineral density among men with osteoporosis at high risk for fracture, according to an industry press release.

Osteoporosis remains highly prevalent among patients with rheumatoid arthritis despite advancements in prevention and treatment, according to data published in Scientific Reports.

A belt device that mechanically stimulates bones through vibration slowed the decline in bone strength among adults with osteopenia, according to top-line results announced in an industry press release.

Recent findings from the Women’s Health Initiative revealed that greater adherence to a plant-based Portfolio diet was associated with a lower risk for incident type 2 diabetes.

PHILADELPHIA — A daily glucocorticoid dose higher than 2.5 mg may lead to irreversible bone mineral density loss regardless of intervention with osteoporosis medications, according to data presented at ACR Convergence 2022.

During the past 20 years, Endocrine Today has covered the latest advancements surrounding osteoporosis care. For its 20th year, the publication is taking a look back.

SAN DIEGO — Matching the correct therapy sequence to the right patient is critical when caring for patients with osteoporosis, according to a speaker at the Congress of Clinical Rheumatology West.

SAN DIEGO — Patients with low bone density may have osteoporosis despite registering a bone mineral density score higher than –2.5, according to a speaker at the Congress of Clinical Rheumatology West

In a post from April about my struggle with osteoporosis, I wrote about my own case of the disease, which was unique in many ways.